A full assessment of all heart valves in rats and mice is often impractical and is usually not performed in routine toxicity studies, largely due to an inevitable inconsistency of histological sampling. The majority of reported heart valve changes involve the examination of a single, semirandom section through the heart and the valvulopathy occurring with age or induced by xenobiotics may have been generally underestimated in mice and rats. Here we describe the incidence and microscopic features of endocardial myxomatous change (EMC) in Hsd:S-D rats and CD-1 mice. EMC was common and widespread in both CD-1 mice and Hsd:S-D rats (188 of 220 rats and 96 of 215 mice were affected by EMC). Microscopically, EMC consisted of focal or segmental thickening of valves, primarily due to the presence of fibromyxoid tissue in the subendocardium. Occasionally, fibrin or thrombi deposits and collection of neutrophils or mononuclear cells were observed. These microscopic features were similar to those seen in valvular disease in humans induced by fenfluramine-phentermine (fen-phen), ergot alkaloids (ergotamine, methysergide), and carcinoid syndrome. The mitral valve in rats and pulmonary valve in mice were most frequently affected. An association between murine progressive cardiomyopathy (MPC) and EMC was noted only in rats, suggesting that there may be a possible relationship between MPC and EMC. However, additional research is needed to confirm a relationship between EMC and MPC in rats and /or mice.
INTRODUCTION
The histologic assessment of all heart valves, namely aortic (semilunar), mitral (left atrioventricular), tricuspid (right atrioventricular) and pulmonary valves in rats and mice is often impractical and usually not performed in routine toxicity studies. The apparent reason is inevitable inconsistency of histological sampling, particularly in rodent hearts. For most standard rodent studies, the heart is sectioned through its longitudinal axis to include one or ideally both the right and left ventricles, interventricular septum, portions of both atria, and major blood vessels at the base of the heart. As a consequence, some sections may contain one or more valves, whereas others may not contain any. The examination of all 4 valves may require multiple serial heart sections or sampling of individual heart valves. Therefore, unless specified for a particular rodent study, it is not a customary or mandatory practice to include the examination of various heart valves in most research organizations, including the pharmaceutical industry and contract research services. The majority of reported heart valve changes involve the examination of a single, semirandom section through the heart (23) , and spontaneous age-related or induced valvulopathies may have been underestimated in mice and rats. There is also a general lack of published reports on aging valvular changes in mice and rats, possibly due to underrepresented heart valve lesions.
All valvular diseases place a hemodynamic burden on the left or right ventricle, or both ventricles, and this overload eventually leads to myocardial dysfunction and congestive heart failure, and sometimes sudden death in humans (4) . Even a subtle, nondestructive valve thickening may result in leaflet restriction and regurgitation. Recently, an association between anorectic drugs and heart valve disorders contributed to major public concern about the use of these drugs and to the subsequent withdrawal of dexfenfluramine and fenfluramine from the US market, including a multibillion dollar settlement by the manufacturer of these drugs (8, 18, 37) . This valvular disorder, recognized clinically and morphologically in humans precipitated further questions about the likelihood of finding similar heart lesions in rodents (mice and rats) or other mammals (eg, dogs) in preclinical toxicity studies (43) . Whether or not the fenfluramine-induced valvulopathy is a human-specific finding, such queries are anticipated when an issue is related to the public safety of a drug. Therefore, a complete pathologic examination, including examination of at least some valves, will help guarantee a directed and accurate diagnosis of valvular abnormalities in routine toxicity studies.
Heart valve disease may be congenital or may be associated with a variety of acquired conditions, such as, infection, trauma, and less frequently, carcinoid syndrome in humans (36) . In addition to fenfluramines, ergot alkaloids such as ergotamine and methysergide have been implicated as a cause 484 ELANGBAM ET AL TOXICOLOGIC PATHOLOGY of valvular disease in humans (8, 17, 19, 32) . Mitral valve thickening has been reported in prenatal rats co-administered with phentermine and dexfenfluramine for 14 days, but no histopathology was performed (3). It is not known that mitral valve thickening in rats (3) may have microscopic features similar to those seen in valvular disease in humans induced by dexfenfluramine and phentermine. Valvular lesions, including myxomatous change have also been induced in rats by several forms of stress (high altitude, cold tumbling, castration, or combinations) (1). Endocardial myxomatous change (EMC) has been described as a spontaneously occurring lesion in aging rats, involving various heart valves (23, 35) . Microscopically, EMC consisted of focal or diffuse thickening of valves, primarily due to the presence of loose myxomatous tissue in the subendocardium. In some cases, there may be hyalinization, unorganized and organized thrombi, accumulation of inflammatory cells and mast cells, and polypoid vegetation (35) . There is a paucity of published reports on the incidence or significance of EMC in rats, and to our best knowledge, this condition has not been previously reported in Hsd:S-D rats and mice of any strain. In this study, we describe the incidence and histological features of age-related EMC in Hsd:S-D rats and CD-1 mice, and its microscopic resemblance to a drug-induced valvulopathy in humans.
MATERIALS AND METHODS
Swiss Crl:CD-1(ICR)BR mice, weighing 18.5 g to 34.0 g (23.2 g to 34.0 g for males and 18.5 g to 26.4 g for females) and Sprague-Dawley Hsd: Sprague-Dawley SD rats, weighing 111 g to 217 g (153 g to 217 g for males and 111 to 170 g for females) were obtained from Charles River Canada (St-Constent, Quebec, Canada) and Harlan Sprague-Dawley Inc, (Indianapolis, Indiana, USA), respectively. The animals were quarantined for 2 weeks and placed on 2-year study at ClinTrials BioResearch (CTBR) Ltd, Quebec, Canada. Rats were housed in groups of 4 of the same sex, but in mice, however, males were housed individually while females were group housed (up to 5 per cage) in stainless-steel, wire meshbottomed cages equipped with an automatic watering valve. Water and feed (PMI certified rodent chow 5002, PMI Feeds Inc, St. Louis, MO, USA) were available ad libitum. Throughout the study animals were observed twice daily for mortality and signs of ill health. From 6 months onwards, clinical observation included manual palpation to facilitate the detection of masses.
During the 2-year study, groups of 120 male and 120 female mice, and 112 male and 112 female rats received deionized water by oral gavage (10 ml/kg, calculated based on the most recent body weight of each animal). All animals received a complete necropsy that included the examination of organs and tissues for gross lesions and collection of standard set of tissues for histologic evaluation. All tissues, including hearts were fixed in 10% neutral buffered formalin, trimmed, embedded in paraffin, sectioned (for heart through its longitudinal axis) at 4-6 µm, stained with hematoxylin and eosin, and examined microscopically. Lesions were described and scored, where appropriate, using subjective grading scales as follows: grade 1 = minimal, grade 2 = mild and grade 3 = moderate. Additional step sections, ranging from 2 to 4 sections (approximately 25 µm between sections) of existing tissue blocks and/or wet tissue processing were carried out for those heart sections with no valves, in the rats only. Occasionally, tissues were removed from the original paraffin blocks and re-embedded with tissues re-oriented (upside down) and sectioned for rat heart valves.
RESULTS

Mortality
A number of mice and rats of both sexes died or were euthanized prior to study completion in a moribund condition and were subsequently examined at necropsy and histologically. The mortality for both sexes ranged from 29-32% in mice and 41-42% in rats, and the major causes of death/euthanasia were hepatic and lung tumors, and malignant lymphoma in mice, whereas chronic progressive nephropathy, pituitary adenoma, mammary gland adenomas/adenocarcinomas, fibroadenomas, and malignant lymphoma were considered to be contributory to early death or euthanasia in rats. None of the animals (mice and rats) were diagnosed with EMC or heart findings as a cause of death.
Heart and Valves
There were no significant macroscopic findings in any of the hearts examined at necropsy. Microscopically, the valvular change consisted of varying degrees of nodular or segmental thickening of affected valves, and thickening was primarily due to fibromyxoid change in the subendocardium (Figures 1-6 ). The fibromyxoid change in the majority of animals was nodular or dome-shaped in outline (gently rounded convexity towards one valvular surface) and located toward the distal free edge of the valve leaflet. Some animals had a plaque-like (flat and thin) or segmental thickening with a broad base along the valve surface. Cellularity within the fibromyxoid area was generally low to moderate, composed of fibroblast-like cells with elongated or round nuclei, depending upon orientation with respect to the plane of section and indistinct cytoplasmic borders that melded with the adjacent lightly basophilic or clear extracellular matrix. The fibromyxoid change was noted in mitral, tricuspid, pulmonary, and aortic valves but showed a strong tendency to involve the ventricular surface of the mitral and aortic valves. Occasionally, fibrin or thrombi deposits and collections of neutrophils or mononuclear cells were seen in the affected valves of few animals (mice and rats). These changes were characteristic of endocardial myxomatous change in rats described by Society of Toxicologic Pathologists' (STP) nomenclature (35) .
The incidence, distribution, and severity of EMC are shown in Tables 1 and 2. The mitral valve was most commonly affected in rats, and this was followed in order of decreasing incidence by the aortic valve, the tricuspid valve, or the pulmonary valve. In contrast, the pulmonary valve was commonly affected in mice. The pulmonary valve was followed in order of decreasing incidence by the mitral valve, the aortic valve, or the tricuspid valve. Occasionally, all 4 valves of 1 heart were affected by EMC in both species. Furthermore, when compared with female rats, male rats had a slightly higher incidence of EMC in mitral and tricuspid valves. However, in mice, there were no apparent differences between 486 ELANGBAM ET AL TOXICOLOGIC PATHOLOGY males and females. The majority of animals with EMC were 500 days or older with a peak incidence between 700-738 days for both males and females in both species. The earliest detected ages for EMC in male and female rats were 124 and 80 days, respectively, and the mitral valve was consistently involved in these animals. In mice, the earliest detected age for EMC was 228 days in males and 157 days in females and was noted in pulmonary and aortic valves. Murine progressive cardiomyopathy (MPC) occurred in both species but at lower severity and incidence in females than in males ( Table 3 ). The earliest detected age for MPC in rats was 124 days in males and 412 days in females while in mice was 218 days in males and 521 days in females. As shown in Table 3 , EMC was associated with MPC in 90.12% and 70.45% of male and female rats, respectively. However, in mice, EMC's association with MPC was lower (35.3% in males and 47.8% in females) than that of rats. The other spontaneous lesions in the heart included atrial thrombosis and polyarteritis. Ten of 111 (9.0%) male rats had varying degrees of atrial thrombosis, and 9 of these rats were associated with EMC and MPC (90%). Atrial thrombosis was not observed in female rats. Similarly in mice, 3 of 6 males (50.0%) and 1 of 2 females (50.0%) had atrial thrombosis associated with EMC. The majority of animals (rats and mice) with atrial thrombosis were 600 days or older with the earliest detected cases at 525 days in rats and 385 days in mice. Our data showed no apparent association between polyarteritis (data not shown) and cardiomyopathy or EMC in either species.
DISCUSSION
Endocardial myxomatous change, characterized by nodular or diffuse thickening of a heart valve with excessive myxomatous tissue in the subendocardium, has been described as a spontaneous lesion in aging rats (2, 22, 35) . To our best knowledge, this condition has not been reported previously in Hsd:S-D rats and mice of any strain. In this study, 188 of 220 rats and 96 of 215 mice were diagnosed with EMC, suggesting that EMC is common and widespread in both CD-1 mice and Hsd:S-D rats. Similar to earlier reports (23, 35) , the majority of animals with EMC in our study were 500 days or older. The earliest detected age with EMC was 80 days in rats and 157 days in mice. Although our data support an association of EMC with aging, there is some uncertainty because animals were not sacrificed at preplanned intervals to specifically characterize the onset of EMC. It is also possible that other factors, including physical status, gavage-related stress, and associated nonspecific lesions (eg, chronic progressive nephropathy, large mammary adenocarcinomas, malignant lymphomas, etc) might have contributed to the early onset of EMC in both mice and rats.
There were apparent differences in the distribution of EMC between mice and rats; the most commonly affected valves were the mitral valve in rats and the pulmonary valve in mice. The increased incidence of mitral valve involvement in rats is expected due to the fact that the mitral valve is the hardest-working valve in the heart [withstands left ventricular systole] (34). However, the significance of increased EMC incidence in the mouse pulmonary valve is unknown. These differences in predilection sites between mice and rats may be due to low sample size, particularly in mice. A specific predilection site has been reported in noninfectious and acquired valvular diseases in humans. For example, metastatic ileocecal carcinoid tumors have been shown to produce tricuspid regurgitation, tricuspid and aortic stenosis, and carcinoid (fibromyxoid) plaques but only mild involvement of the mitral valve. In contrast, when the carcinoid is of bronchial origin, the valvular lesions produced are more predominantly left heart than right heart (33) . Fenfluramineassociated valvulopathy has been shown to have a marked predilection toward involvement of left-sided valves (14, 21, 31, 38) .
In agreement with previously published microscopic findings in rats (35) , all affected valves in this study had varying degrees of fibromyxoid proliferation with or without infiltration of inflammatory cells in the subendocardium. These microscopic features were virtually comparable to those of valvular disease in humans induced by ergot alkaloids (ergotamine, methysergide), fenfluramine-phentermine (fen-phen), and carcinoid syndrome. The microscopic feature common to all these conditions included a subendocardial or superficial fibromyxoid change of the valvular leaflets (38) . A similar fibromyxoid change may be observed in the mitral valve prolapse (MVP) in dogs and humans (28, 38) . The exact mechanism for these conditions is not known, however, endothelin and serotonin hypotheses have been proposed to explain the mechanism of subendothelial myxomatous proliferation in canine and human heart valves. A strong correlation has been shown between the endothelinreceptor density and the degree of myxomatous change in canine mitral valve leaflets, suggesting that endothelin plays a major pathogenetic role (27) . Endothelin is known to play an important role in restenosis with percutaneous transluminal coronary angioplasty in which endothelial damage leads to subendothelial changes (9, 39) . The "serotonin hypothesis" was originated from the observation that a marked elevation of serum serotonin and its metabolites is characteristically noted in valvular disease caused by carcinoid syndrome (30, 33) . Because of the morphologic similarity between fenfluramine-associated and carcinoid-induced lesions, it has been proposed that increased blood levels of serotonin and/or its metabolites may be responsible for the fenfluramine-associated lesion (8) . In addition, high shear forces imposed on platelets against valve endothelium may enhance local release of serotonin on the surface of the valve (5) . Accordingly, quiescent fibroblasts within the valve leaflet may be induced to proliferate and migrate across the valve endothelium and secrete an extracellular matrix to consolidate the plaque-like lesion (42) . However, these theories remain to be proven.
The significance of EMC in rats and mice is largely unknown. In this study, none of the animals were diagnosed with EMC as a cause of death. However, the thickened valves in EMC may result in obstruction (stenosis) to blood flow or allow retrograde blood flow (valvular regurgitation or insufficiency). Stenosis of a cardiac valve may result in hypertrophy secondary to pressure overload with eventual myocardial degeneration, and dilatation of the chamber proximal to the valve. Similarly, valvular regurgitation or insufficiency results in myocardial hypertrophy, degeneration, and dilatation of cardiac chamber proximal to the valve, primarily due to volume overload. In this study, myocardial hypertrophy was not diagnosed in any of the animals (mice and rats), including those affected with EMC. The detection of myocardial hypertrophy in the absence of cardiac weight (not measured in this study) is often difficult microscopically, and morphometric techniques may be required to confirm the diagnosis (16) . It is also possible that cardiac hypertrophy, despite its existence was beyond the limits of microscopic detection.
In this study, the majority of rats with EMC had also MPC whereas a few had only EMC or MPC. This association between EMC and MPC in rats suggests a possible relationship between these 2 conditions. EMC is likely to produce volume overload to the cardiac chamber proximal to the affected valve with development of myocardial hypertrophy, and subsequent degeneration and inflammation, which may resemble typical changes of MPC and/or exacerbation of existing MPC. MPC is common in Han Wistar rats and other strains, and occurs at higher prevalence in older males (29) . Females have less extensive changes than males of the same age (29) . Similarly, MPC occurs in mice of various strains (10, 40) . Although MPC is a common aging change in rats, its association with EMC or any valvular changes has not previously been reported. Earlier reports have sug-gested that diet, environment, and stress influence the severity and age of onset in both mice and rats (24) . In view of the sampling problems and unevaluated lesions in the murine valves, it is perhaps not surprising that review of spontaneous heart lesions in aged rats or mice failed to include EMC. However, further studies are required to determine the progression of EMC and to characterize further complications, including MPC, bacterial endocarditis, and/or congestive cardiac failure. It is also possible that MPC and EMC may occur independently as has been reported anecdotally (10, 23, 29, 40) . Atrial thrombosis has been described in the aged rats and mice, and is often associated with myocardial lesions, such as degeneration, focal inflammation, mineralization, amyloid deposition, or degenerative myxoid lesions in the heart valves (15) . Ninety percent of rats and 50% of mice with atrial thrombosis in this study were accompanied by EMC. Atrial thrombosis is relatively uncommon in Wistar strains and has not been reported in studies with Fischer rats (7, 13, 25) or Hsd:S-D rats (29) . It occurs in aged rats and more often in males than in females. The incidence of atrial thrombosis (9.0%) in this study was comparable to Wistar CPB rats (20) . Similar to previous reports, most animals in this study were 600 days or older with the earliest detected case in a 525-dayold rat. Our data showed a low incidence of atrial thrombosis in CD-1 mice. In contrast, atrial thrombosis has been reported as a common lesion in certain strains of mice and a major cause of mortality (26) . For example, in BALB/c strain, the reported incidence of left atrial thrombosis was 65% (11) . Dietary factors including copper deficiency and fat intake have been shown to increase the incidence of atrial thrombosis in various strains of mice. Feeding a thrombogenic diet with lard at 6%, 28%, and 40% in RF mice resulted in 30%, 36% and 65% incidence of atrial thrombosis, respectively (6) . Mice fed with butter have been shown to have the highest frequency (92%) of atrial thrombosis (41) . More recently, atrial thrombosis has been described in mice treated with doxorubicin (12, 15) .
In summary, EMC has a strong microscopic resemblance to valvular disease in humans induced by ergot alkaloids (ergotamine, methysergide), fenfluramine-phentermine and carcinoid syndrome. EMC is also common and widespread in both CD-1 mice and Hsd:S-D rats. The mitral valve in rats and pulmonary valve in mice were most frequently affected. An association between MPC and EMC was noted for rats, suggesting that MPC may be related to EMC. Additional research is needed to confirm a relationship between EMC and MPC in rats and/or mice. Furthermore, drug-induced valvular disease or chemically exacerbated EMC may occur in both rats and mice, and accordingly, a complete pathologic evaluation, including examination of at least some valves will help guarantee a directed and accurate diagnosis of valvular abnormalities in routine toxicity studies.
